Sean Escola

Neuroscience. AI. Psychiatry.
I have had the privilege of working in several diverse and interesting settings:
- I recently joined Protocol Labs as Neurotech and NeuroAI Lead.
- I co-founded Herophilus, a biotechnology company that combined patient-derived stem cell cultures (“organoids”) with advanced neuroassays and machine learning for drug discovery. As founding CEO in 2017–2020, I raised $30M in venture financing and hired a team of >40 scientists. We sold Herophilus’s technology to Genentech in 2023.
- I led a computational neuroscience lab as an Assistant Professor at Columbia University in the Department of Psychiatry and affiliate of the Center for Theoretical Neuroscience. The lab studied how natural intelligence can inform artificial intelligence, specifically by examining the neural circuit computations that underlie motor control and learning. We also studied neural network theory and the circuit mechanisms underlying psychopathology.
- I co-founded Neuromatch, a worldwide 501(c)3 non-profit that is democratizing science by providing high quality education, targeted interactions, career support, and open publishing with zero financial barrier to entry for all. I raised $2M in philanthropy for initial operating capital in 2020–2021 and I served on the Board of Directors (2020–2024).
- I am also a clinical psychiatrist with a small private practice where I see adult patients for medication management and psychotherapy.
latest posts
May 16, 2024 | Proposal for a NeuroAI FRO |
---|